Literature DB >> 24145876

Reply to Gandra et al.

Anne-Catrin Uhlemann1, Franklin D Lowy.   

Abstract

Mesh：

Year:  2013        PMID： 24145876      PMCID： PMC3871791          DOI： 10.1093/cid/cit685

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Is methicillin-susceptible Staphylococcus aureus (MSSA) sequence type 398 confined to Northern Manhattan? Rising prevalence of erythromycin- and clindamycin-resistant MSSA clinical isolates in the United States.

Authors:  Sumanth Gandra; Nikolay Braykov; Ramanan Laxminarayan
Journal:  Clin Infect Dis       Date:  2013-10-21       Impact factor: 9.079

2.  Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.

Authors:  Stien Vandendriessche; Kristina Kadlec; Stefan Schwarz; Olivier Denis
Journal:  J Antimicrob Chemother       Date:  2011-08-25       Impact factor: 5.790

3.  Molecular characterization of methicillin-susceptible Staphylococcus aureus clinical isolates in the United States, 2004 to 2010.

Authors:  Benjamin A Miko; Cory A Hafer; Caroline J Lee; Sean B Sullivan; Meredith A M Hackel; Brian M Johnson; Susan Whittier; Phyllis Della-Latta; Anne-Catrin Uhlemann; Franklin D Lowy
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

4.  Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials.

Authors:  Richard V Goering; Ribhi M Shawar; Nicole E Scangarella; F Patrick O'Hara; Heather Amrine-Madsen; Joshua M West; Marybeth Dalessandro; Julie A Becker; Stacey L Walsh; Linda A Miller; Stephanie F van Horn; Elizabeth S Thomas; Monique E Twynholm
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

5.  Emergence of sequence type 398 as a community- and healthcare-associated methicillin-susceptible staphylococcus aureus in northern Manhattan.

Authors:  Anne-Catrin Uhlemann; Cory Hafer; Benjamin A Miko; Madeleine G Sowash; Sean B Sullivan; Qiuhu Shu; Franklin D Lowy
Journal:  Clin Infect Dis       Date:  2013-05-31       Impact factor: 9.079

6.  Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties.

Authors:  Anne-Catrin Uhlemann; Stephen F Porcella; Sheetal Trivedi; Sean B Sullivan; Cory Hafer; Adam D Kennedy; Kent D Barbian; Alex J McCarthy; Craig Street; David L Hirschberg; W Ian Lipkin; Jodi A Lindsay; Frank R DeLeo; Franklin D Lowy
Journal:  mBio       Date:  2012-02-28       Impact factor: 7.867

7.  Methicillin-susceptible Staphylococcus aureus ST398, New York and New Jersey, USA.

Authors:  José R Mediavilla; Liang Chen; Anne-Catrin Uhlemann; Blake M Hanson; Marnie Rosenthal; Kathryn Stanak; Brian Koll; Bettina C Fries; Donna Armellino; Mary Ellen Schilling; Don Weiss; Tara C Smith; Franklin D Lowy; Barry N Kreiswirth
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

8.  Recent emergence of Staphylococcus aureus clonal complex 398 in human blood cultures.

Authors:  Erwin Verkade; Anneke M C Bergmans; Andries E Budding; Alex van Belkum; Paul Savelkoul; Anton G Buiting; Jan Kluytmans
Journal:  PLoS One       Date:  2012-10-18       Impact factor: 3.240

9.  Staphylococcus aureus ST398, New York City and Dominican Republic.

Authors:  Meera Bhat; Caroline Dumortier; Barbara S Taylor; Maureen Miller; Glenny Vasquez; Jose Yunen; Karen Brudney; Jacqueline Sánchez-E; Carlos Rodriguez-Taveras; Rita Rojas; Patricia Leon; Franklin D Lowy
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883
  9 in total
  1 in total

1.  Diffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014.

Authors:  Margaret Carrel; Michihiko Goto; Marin L Schweizer; Michael Z David; Daniel Livorsi; Eli N Perencevich
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-05       Impact factor: 4.887
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.